Risk Factors for Pathologically Confirmed Lymph Nodes Metastasis in Patients With Clinical T2N0M0 Stage Prostate Cancer

ObjectiveTo explore the risk factors for postoperatively pathological lymph node metastasis in patients with clinical T2N0M0 stage prostate cancer (PCa).MethodsWe retrospectively analyzed clinicopathological data of 316 patients with clinical T2 stage PCa and preoperative negative lymph nodes [LN(−)...

Full description

Bibliographic Details
Main Authors: Ning Xu, Zhi-Bin Ke, Ye-Hui Chen, Yu-Peng Wu, Shao-Hao Chen, Yong Wei, Qing-Shui Zheng, Jin-Bei Huang, Xiao-Dong Li, Xue-Yi Xue
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-08-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fonc.2020.01547/full
id doaj-436cd5a803d648d88aeb2b14c40d06ff
record_format Article
spelling doaj-436cd5a803d648d88aeb2b14c40d06ff2020-11-25T03:27:47ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2020-08-011010.3389/fonc.2020.01547518488Risk Factors for Pathologically Confirmed Lymph Nodes Metastasis in Patients With Clinical T2N0M0 Stage Prostate CancerNing XuZhi-Bin KeYe-Hui ChenYu-Peng WuShao-Hao ChenYong WeiQing-Shui ZhengJin-Bei HuangXiao-Dong LiXue-Yi XueObjectiveTo explore the risk factors for postoperatively pathological lymph node metastasis in patients with clinical T2N0M0 stage prostate cancer (PCa).MethodsWe retrospectively analyzed clinicopathological data of 316 patients with clinical T2 stage PCa and preoperative negative lymph nodes [LN(−)] indicated by imaging (cT2N0M0) between January 2014 and May 2019. Multivariate logistic regression analysis was performed to determine risk factors for postoperatively pathological pLN(+) in patients with cT2N0M0 stage PCa. Spearman correlation analysis was used to explore the relationship between tumor burden and Prostate Imaging Reporting and Data System version 2 (PI-RADS v2) score.ResultsA total of 45 patients (14.2%) were confirmed by postoperative pathology to have LN metastasis. Univariate analysis indicated that total prostate-specific antigen (tPSA), PI-RADS v2 score, postoperative Gleason grade group (GGG), intraductal carcinoma of the prostate (IDC-P), clinical T2 substaging, and postoperative pathological tumor burden were risk factors for pLN(+) in all patients. Multivariate analysis showed that tPSA and postoperative GGG were risk factors for pLN(+) in all patients. Univariate analysis revealed that tPSA, PIRADS v2 score, clinical T2 substaging, IDC-P, postoperative pathological tumor burden, and postoperative GGG were risk factors for pLN(+) in patients with GGG ≥ 3. Multivariate analysis suggested that tPSA, PI-RADS v2 score, clinical T2 substaging, postoperative pathological tumor burden, and GGG were risk factors for pLN (+) in patients with GGG ≥ 3. Spearman correlation analysis showed that PI-RADS v2 score was positively correlated with clinical T2 substaging and postoperative pathological tumor burden.ConclusionThere was a high risk of LN metastasis in patients with cT2 PCa if they had high preoperative tPSA or high postoperative GGG. Patients with cT2 PCa and GGG ≥ 3 had a high risk of LN metastasis if they had high PI-RADS v2 score, high preoperative clinical stage or high postoperative pathological tumor burden. PI-RADS v2 score predicted tumor burden well in patients with GGG ≥ 3.https://www.frontiersin.org/article/10.3389/fonc.2020.01547/fullPI-RADStumor burdenGleason grading grouplymph node metastasisprostate cancer
collection DOAJ
language English
format Article
sources DOAJ
author Ning Xu
Zhi-Bin Ke
Ye-Hui Chen
Yu-Peng Wu
Shao-Hao Chen
Yong Wei
Qing-Shui Zheng
Jin-Bei Huang
Xiao-Dong Li
Xue-Yi Xue
spellingShingle Ning Xu
Zhi-Bin Ke
Ye-Hui Chen
Yu-Peng Wu
Shao-Hao Chen
Yong Wei
Qing-Shui Zheng
Jin-Bei Huang
Xiao-Dong Li
Xue-Yi Xue
Risk Factors for Pathologically Confirmed Lymph Nodes Metastasis in Patients With Clinical T2N0M0 Stage Prostate Cancer
Frontiers in Oncology
PI-RADS
tumor burden
Gleason grading group
lymph node metastasis
prostate cancer
author_facet Ning Xu
Zhi-Bin Ke
Ye-Hui Chen
Yu-Peng Wu
Shao-Hao Chen
Yong Wei
Qing-Shui Zheng
Jin-Bei Huang
Xiao-Dong Li
Xue-Yi Xue
author_sort Ning Xu
title Risk Factors for Pathologically Confirmed Lymph Nodes Metastasis in Patients With Clinical T2N0M0 Stage Prostate Cancer
title_short Risk Factors for Pathologically Confirmed Lymph Nodes Metastasis in Patients With Clinical T2N0M0 Stage Prostate Cancer
title_full Risk Factors for Pathologically Confirmed Lymph Nodes Metastasis in Patients With Clinical T2N0M0 Stage Prostate Cancer
title_fullStr Risk Factors for Pathologically Confirmed Lymph Nodes Metastasis in Patients With Clinical T2N0M0 Stage Prostate Cancer
title_full_unstemmed Risk Factors for Pathologically Confirmed Lymph Nodes Metastasis in Patients With Clinical T2N0M0 Stage Prostate Cancer
title_sort risk factors for pathologically confirmed lymph nodes metastasis in patients with clinical t2n0m0 stage prostate cancer
publisher Frontiers Media S.A.
series Frontiers in Oncology
issn 2234-943X
publishDate 2020-08-01
description ObjectiveTo explore the risk factors for postoperatively pathological lymph node metastasis in patients with clinical T2N0M0 stage prostate cancer (PCa).MethodsWe retrospectively analyzed clinicopathological data of 316 patients with clinical T2 stage PCa and preoperative negative lymph nodes [LN(−)] indicated by imaging (cT2N0M0) between January 2014 and May 2019. Multivariate logistic regression analysis was performed to determine risk factors for postoperatively pathological pLN(+) in patients with cT2N0M0 stage PCa. Spearman correlation analysis was used to explore the relationship between tumor burden and Prostate Imaging Reporting and Data System version 2 (PI-RADS v2) score.ResultsA total of 45 patients (14.2%) were confirmed by postoperative pathology to have LN metastasis. Univariate analysis indicated that total prostate-specific antigen (tPSA), PI-RADS v2 score, postoperative Gleason grade group (GGG), intraductal carcinoma of the prostate (IDC-P), clinical T2 substaging, and postoperative pathological tumor burden were risk factors for pLN(+) in all patients. Multivariate analysis showed that tPSA and postoperative GGG were risk factors for pLN(+) in all patients. Univariate analysis revealed that tPSA, PIRADS v2 score, clinical T2 substaging, IDC-P, postoperative pathological tumor burden, and postoperative GGG were risk factors for pLN(+) in patients with GGG ≥ 3. Multivariate analysis suggested that tPSA, PI-RADS v2 score, clinical T2 substaging, postoperative pathological tumor burden, and GGG were risk factors for pLN (+) in patients with GGG ≥ 3. Spearman correlation analysis showed that PI-RADS v2 score was positively correlated with clinical T2 substaging and postoperative pathological tumor burden.ConclusionThere was a high risk of LN metastasis in patients with cT2 PCa if they had high preoperative tPSA or high postoperative GGG. Patients with cT2 PCa and GGG ≥ 3 had a high risk of LN metastasis if they had high PI-RADS v2 score, high preoperative clinical stage or high postoperative pathological tumor burden. PI-RADS v2 score predicted tumor burden well in patients with GGG ≥ 3.
topic PI-RADS
tumor burden
Gleason grading group
lymph node metastasis
prostate cancer
url https://www.frontiersin.org/article/10.3389/fonc.2020.01547/full
work_keys_str_mv AT ningxu riskfactorsforpathologicallyconfirmedlymphnodesmetastasisinpatientswithclinicalt2n0m0stageprostatecancer
AT zhibinke riskfactorsforpathologicallyconfirmedlymphnodesmetastasisinpatientswithclinicalt2n0m0stageprostatecancer
AT yehuichen riskfactorsforpathologicallyconfirmedlymphnodesmetastasisinpatientswithclinicalt2n0m0stageprostatecancer
AT yupengwu riskfactorsforpathologicallyconfirmedlymphnodesmetastasisinpatientswithclinicalt2n0m0stageprostatecancer
AT shaohaochen riskfactorsforpathologicallyconfirmedlymphnodesmetastasisinpatientswithclinicalt2n0m0stageprostatecancer
AT yongwei riskfactorsforpathologicallyconfirmedlymphnodesmetastasisinpatientswithclinicalt2n0m0stageprostatecancer
AT qingshuizheng riskfactorsforpathologicallyconfirmedlymphnodesmetastasisinpatientswithclinicalt2n0m0stageprostatecancer
AT jinbeihuang riskfactorsforpathologicallyconfirmedlymphnodesmetastasisinpatientswithclinicalt2n0m0stageprostatecancer
AT xiaodongli riskfactorsforpathologicallyconfirmedlymphnodesmetastasisinpatientswithclinicalt2n0m0stageprostatecancer
AT xueyixue riskfactorsforpathologicallyconfirmedlymphnodesmetastasisinpatientswithclinicalt2n0m0stageprostatecancer
_version_ 1724587091764969472